Design of probes specific for PSMA or NAALADaseL1 to identify early stage neuroendocrine-like prostate cancer

  1. Home
  2. Research
  3. Funded Projects
  4. Design of probes specific for PSMA or NAALADaseL1 to identify early stage neuroendocrine-like prostate cancer
Design of probes specific for PSMA or NAALADaseL1 to identify early stage neuroendocrine-like prostate cancer

Dr. John Trant

University of Windsor

FUNDER: WE-SPARK Health Institute

GRANT DURATION: 2021-2022

Related Programs:
Nucleus Cores:

The project aims to provide a pair of probes to distinguish between PSMA-positive prostate cancer and NAALADaseL1 positive prostate cancer (associated with neuroendocrine and likely treatment resistant). It can also help determine if a cancer is progressing from one stage to another.

CO-INVESTIGATORS

University of Windsor

  • Dr. Lisa Porter
Loading...